Targeting FoxP3 gene to check out the impairment of tolerance in breast cancer patients

Alvarado-Sánchez, 2006, Regulatory T cells in patients with systemic lupus rythematosus, J. Autoimmun., 27, 110, 10.1016/j.jaut.2006.06.005 Arabpour, 2018, FoxP3 gene polymorphism is associated with breast cancer in Iranian patients, Exp. Oncol., 40, 309, 10.31768/2312-8852.2018.40(4):309-314 Bennett CL, Yoshioka R, Kiyosawa H, Barker DF, Fain PR, Shigeoka AO et al. (2000). X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11. 23-Xq1. Am. J. Human Genet. 66:461. Chandira, 2019, BRCA mutation: A review of breast cancer, J. Drug Deliv. Therap., 9, 617 Cheng, 2018, Functional Foxp3 polymorphisms and the susceptibility to cancer: An update meta-analysis, Medicine, 97, 10.1097/MD.0000000000011927 Colditz, 2012, Family history a risk of breast cancer: nurses’ health study, Breast Cancer Res. Treat., 133, 1097, 10.1007/s10549-012-1985-9 Curiel, 2004, Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival, Nat. Med., 10, 942, 10.1038/nm1093 Forte, 2012, Obesity, diabetes, the cardiorenal syndrome, and risk for cancer, Cardiorenal Med., 2, 143, 10.1159/000337314 Fu, 2007, Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients, Gastroenterology, 132, 2328, 10.1053/j.gastro.2007.03.102 Gage, 2014, Translational advances regarding hereditary breast cancer syndromes, J. Surg. Oncol., 105, 444, 10.1002/jso.21856 Gao, 2013, Insertion/deletion polymorphisms in the promoter region of BRM contribute to risk of hepatocellular carcinoma in Chinese populations, PLoS ONE, 8 Hayes, 2013, Population attributable risks for modifiable lifestyle factors and breast cancer in New Zealand women, Internal Med. J., 43, 1198, 10.1111/imj.12256 Hinz, 2007, Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer, Cancer Res., 67, 8344, 10.1158/0008-5472.CAN-06-3304 Idrees, 2018, Cancer prevalence in Pakistan: meta-analysis of various published studies to determine variation in cancer figures resulting from marked population heterogeneity in different parts of the country, World. J. Surg. Oncol., 16, 129, 10.1186/s12957-018-1429-z Katoh, 2011, FOXP3 orchestrates H4K16 acetylation and H3K4 trimethylation for activation of multiple genes by recruiting MOF and causing displacement of PLU-1, Mol. Cell, 44, 770, 10.1016/j.molcel.2011.10.012 Leo, 2017, Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study, PLoS Genet., 13, 10.1371/journal.pgen.1006866 Lopes, 2014, FOXP3 transcription factor: a candidate marker for susceptibility and prognosis in triple negative breast cancer, BioMed Res. Int., 14, 341 Marson, 2007, Foxp3 occupancy and regulation of key target genes during T-cell stimulation, Nature, 445, 931, 10.1038/nature05478 Nishikawa, 2010, Regulatory T cells in tumor immunity, Int. J. Cancer, 127, 759, 10.1002/ijc.25429 Oda, 2013, Genetic polymorphism in FOXP3 gene: imbalance in regulatory T-cell role and development of human diseases, J. Genet., 92, 163, 10.1007/s12041-013-0213-7 Pesu, 2008, T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance, Nature, 455, 246, 10.1038/nature07210 Rudensky, 2011, Regulatory T cells and Foxp3, Immunol. Rev., 241, 260, 10.1111/j.1600-065X.2011.01018.x Sakaguchi, 2004, Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses, Annu. Rev. Immunol., 22, 531, 10.1146/annurev.immunol.21.120601.141122 Sakai, 2017, Clonal composition of human ovarian cancer based on copy number analysis reveals a reciprocal relation with oncogenic mutation status, Cancer Lett., 405, 22, 10.1016/j.canlet.2017.07.013 Schreiber, 2011, Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion, Science, 331, 1565, 10.1126/science.1203486 Shevach, 2006, The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells, Immunol. Rev., 212, 60, 10.1111/j.0105-2896.2006.00415.x Smith, 2006, Robinson MK: Splice variants of human FOXP3 are functional inhibitors of human CD4+ T-cell activation, Immunology, 119, 203, 10.1111/j.1365-2567.2006.02425.x Tang, 2008, The Foxp3+ regulatory T cell: a jack of all trades, master of regulation, Nat. Immunol., 9, 239, 10.1038/ni1572 Ugolini, 2014, FoxP3 expression in papillary thyroid carcinoma: a possible resistance biomarker to iodine 131 treatment, Thyroid, 24, 339, 10.1089/thy.2012.0589 Wang, 2016, Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet, 388, 1459, 10.1016/S0140-6736(16)31012-1 Yamagami, 2011, Immunofluorescence-detected infiltration of CD4+FOXP3+ regulatory T cells is relevant to the prognosis of patients with endometrial cancer, Int. J. Gynecol. Cancer, 21, 1628, 10.1097/IGC.0b013e31822c271f Zheng, 2017, Functional miR-146a, miR-149, miR-196a2 and miR-499 polymorphisms and the susceptibility to hepatocellular carcinoma: an updated meta-analysis, Clin. Res. Hepatol. Gastroenterol., 41, 664, 10.1016/j.clinre.2017.03.005